Metropolitan Life Insurance Company (MetLife)’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40,148
| Closed | -$1.51M | – | 721 |
|
|
2024
Q1 | $1.51M | Sell |
40,148
-370
| -0.9% | -$13.2K | 0.07% | 255 |
|
|
2023
Q4 | $1.45M | Sell |
40,518
-658
| -2% | -$25.3K | 0.07% | 250 |
|
|
2023
Q3 | $1.56M | Sell |
41,176
-2,166
| -5% | -$88.3K | 0.08% | 209 |
|
|
2023
Q2 | $1.77M | Sell |
43,342
-1,105
| -2% | -$45.7K | 0.09% | 203 |
|
|
2023
Q1 | $1.86M | Sell |
44,447
-13,029
| -23% | -$543K | 0.1% | 188 |
|
|
2022
Q4 | $2.48M | Sell |
57,476
-1,569
| -3% | -$62K | 0.11% | 181 |
|
|
2022
Q3 | $2.21M | Buy |
59,045
+7
| +0% | +$310 | 0.1% | 187 |
|
|
2022
Q2 | $2.68M | Sell |
59,038
-1,407
| -2% | -$66.2K | 0.12% | 170 |
|
|
2022
Q1 | $2.88M | Sell |
60,445
-96,287
| -61% | -$4.08M | 0.1% | 186 |
|
|
2021
Q4 | $6.46M | Sell |
156,732
-4,478
| -3% | -$169K | 0.09% | 182 |
|
|
2021
Q3 | $5.56M | Sell |
161,210
-5,381
| -3% | -$184K | 0.08% | 191 |
|
|
2021
Q2 | $5.27M | Sell |
166,591
-2,427
| -1% | -$78.1K | 0.07% | 209 |
|
|
2021
Q1 | $5.27M | Sell |
169,018
-8,220
| -5% | -$247K | 0.08% | 194 |
|
|
2020
Q4 | $5.34M | Sell |
177,238
-9,260
| -5% | -$273K | 0.08% | 195 |
|
|
2020
Q3 | $4.76M | Sell |
186,498
-8,224
| -4% | -$218K | 0.08% | 193 |
|
|
2020
Q2 | $5.04M | Sell |
194,722
-11,421
| -6% | -$303K | 0.09% | 181 |
|
|
2020
Q1 | $5.41M | Sell |
206,143
-788
| -0.4% | -$24.8K | 0.11% | 157 |
|
|
2019
Q4 | $6.73M | Buy |
206,931
+575
| +0.3% | +$18.6K | 0.11% | 166 |
|
|
2019
Q3 | $7.11M | Buy |
206,356
+971
| +0.5% | +$32.6K | 0.12% | 152 |
|
|
2019
Q2 | $7.02M | Buy |
205,385
+13,147
| +7% | +$464K | 0.12% | 152 |
|
|
2019
Q1 | $6.87M | Sell |
192,238
-4,679
| -2% | -$159K | 0.12% | 144 |
|
|
2018
Q4 | $6.33M | Sell |
196,917
-576
| -0.3% | -$18.4K | 0.13% | 142 |
|
|
2018
Q3 | $6.15M | Sell |
197,493
-7,314
| -4% | -$225K | 0.1% | 171 |
|
|
2018
Q2 | $6.22M | Sell |
204,807
-5,860
| -3% | -$168K | 0.1% | 179 |
|
|
2018
Q1 | $5.86M | Buy |
210,667
+2,142
| +1% | +$57.8K | 0.08% | 191 |
|
|
2017
Q4 | $5.86M | Sell |
208,525
-430,645
| -67% | -$12.4M | 0.08% | 187 |
|
|
2017
Q3 | $17.2M | Buy |
639,170
+9,577
| +2% | +$256K | 0.11% | 165 |
|
|
2017
Q2 | $16.2M | Sell |
629,593
-15,549
| -2% | -$396K | 0.11% | 173 |
|
|
2017
Q1 | $16.6M | Sell |
645,142
-7,837
| -1% | -$200K | 0.11% | 163 |
|
|
2016
Q4 | $16.5M | Sell |
652,979
-15,511
| -2% | -$368K | 0.12% | 162 |
|
|
2016
Q3 | $15.9M | Sell |
668,490
-3,955
| -0.6% | -$99.4K | 0.12% | 165 |
|
|
2016
Q2 | $17.4M | Sell |
672,445
-6,845
| -1% | -$169K | 0.13% | 146 |
|
|
2016
Q1 | $17.4M | Sell |
679,290
-14,086
| -2% | -$316K | 0.13% | 142 |
|
|
2015
Q4 | $13.7M | Buy |
693,376
+32,135
| +5% | +$651K | 0.11% | 184 |
|
|
2015
Q3 | $14M | Sell |
661,241
-11,725
| -2% | -$264K | 0.1% | 189 |
|
|
2015
Q2 | $15.1M | Sell |
672,966
-4,371
| -0.6% | -$105K | 0.11% | 185 |
|
|
2015
Q1 | $16.2M | Sell |
677,337
-8,505
| -1% | -$211K | 0.12% | 177 |
|
|
2014
Q4 | $18.1M | Sell |
685,842
-4,958
| -0.7% | -$127K | 0.13% | 162 |
|
|
2014
Q3 | $16.8M | Sell |
690,800
-9,606
| -1% | -$225K | 0.12% | 167 |
|
|
2014
Q2 | $18.2M | Sell |
700,406
-33,155
| -5% | -$846K | 0.13% | 163 |
|
|
2014
Q1 | $17.6M | Sell |
733,561
-10,813
| -1% | -$228K | 0.12% | 168 |
|
|
2013
Q4 | $14.5M | Sell |
744,374
-14,879
| -2% | -$299K | 0.1% | 198 |
|
|
2013
Q3 | $16.1M | Sell |
759,253
-3,330
| -0.4% | -$72.8K | 0.12% | 157 |
|
|
2013
Q2 | $16.8M | Buy |
+762,583
| New | +$18.5M | 0.13% | 145 |
|
Other funds holding EXC
Metropolitan Life Insurance Company (MetLife)'s EXC Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Exelon (EXC) in Q2 2024, closing a stake of 40,148 shares — an estimated $1.51M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in EXC in Q2 2013 and held it in 44 quarters. The position peaked at $18.2M in Q2 2014. 990 funds tracked by Wall St. Rank hold EXC as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Exelon position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 40,148 Exelon shares in Q2 2024, an estimated $1.51M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Exelon in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Exelon position peaked at $18.2M in Q2 2014.
- 990 funds tracked by Wall St. Rank held Exelon as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.